What is the clinical evidence from this study?

Study design: Cohort. Population: Superior sinus venosus defects (n=30). Intervention: Transcatheter correction with OPTIMUS XXL partially covered stent. Primary outcome: Procedural success.

What question did this study set out to answer?

This study aims to assess the safety and efficacy of transcatheter correction for superior sinus venosus defects using the OPTIMUS XXL® stent.

February 20, 2026European Heart Journal

Transcatheter correction of superior sinus venosus defects: early and mid-term results in a prospective, nationwide, multi-center study

View Full Paper

Ask AI

Bookmark

Key result

Transcatheter sinus venosus defect closure with OPTIMUS XXL stents achieves 100% procedural success at 6 months.

n=30

Why the study?

Is transcatheter correction using the OPTIMUS XXL partially covered stent safe and effective in adults with superior sinus venosus defects?

Population

30 adults with superior sinus venosus defects (SVDs), mean age 61 years, 73% female.

Design

Cohort

Follow-up

6 months

Authors

GAG AlbenqueHôpital Marie Lannelongue CBC BatteuxHôpital Marie Lannelongue CKC Karsenty

Discussion

Member takes

Implication

Transcatheter correction of superior sinus venosus defects using the OPTIMUS XXL partially covered stent appears safe and effective with excellent early and mid-term outcomes.

Key Points

This study aims to assess the safety and efficacy of transcatheter correction for superior sinus venosus defects using the OPTIMUS XXL® stent.
Prospective, nationwide, multi-center cohort study
Included 60 consecutive patients starting June 2023
Evaluated early and mid-term (6 months) outcomes
Virtual simulations and 3D printed models used for all procedures
Stents of 100mm and 80mm were implanted in respective cases.
All procedures were successful with no reported peri-procedural deaths
Pulmonary vein pathway protected in 57% of cases
Moderate pericardial effusion observed in one patient, resolved spontaneously
No significant residual shunt or other related adverse events were found

Study Design

Type

Cohort (n=30)

Multicenter

Yes

Structured PICO

Is transcatheter correction using the OPTIMUS XXL partially covered stent safe and effective in adults with superior sinus venosus defects?

Population

30 adults (mean age 61 years, 73% female) undergoing transcatheter correction of superior sinus venosus defects, followed for 6 months.

Exposure

Transcatheter correction using the OPTIMUS XXL partially covered stent.

Outcome

Efficacy and safety (early and mid-term 6 months outcomes).safety

Transcatheter correction of superior sinus venosus defects using the OPTIMUS XXL partially covered stent appears safe and effective with excellent early and mid-term outcomes.

Cite This Study

Albenque et al. (2025) conducted a cohort in Superior sinus venosus defects (n=30). Transcatheter correction with OPTIMUS XXL partially covered stent was evaluated on Procedural success. Transcatheter correction of superior sinus venosus defects using OPTIMUS XXL covered stents achieved 100% procedural success with no peri-procedural deaths at 6 months.

synapsesocial.com/papers/6997fa80ad1d9b11b3453bc8 https://doi.org/10.1093/eurheartj/ehaf784.2813

View Full Paper

Ask AI

Bookmark

Implication

Transcatheter correction of superior sinus venosus defects using the OPTIMUS XXL partially covered stent appears safe and effective with excellent early and mid-term outcomes.

Transcatheter correction of superior sinus venosus defects: early and mid-term results in a prospective, nationwide, multi-center study

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Cite This Study

Transcatheter correction of superior sinus venosus defects: early and mid-term results in a prospective, nationwide, multi-center study

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Cite This Study

Also Consider

Also Consider